海利生物：拟使用5.00亿元自有资金委托理财

Core Viewpoint - The company plans to invest up to 500 million yuan of its idle funds in various financial products, including bank wealth management products, securities firm wealth management products, trust wealth management products, and public or private funds issued by other financial institutions [1] Group 1 - The investment will utilize a maximum daily balance of 500 million yuan [1] - The funding source for this investment will be the company's idle self-owned funds [1] - The decision has been approved by the company's fifth board of directors in its seventeenth meeting and does not require shareholder approval [1] Group 2 - The investment authorization is valid for 12 months from the date of board approval [1]